Traders Eye $850 Million ThomasLloyd Deal as Roman DBDR Stock Stays Quiet

May 27, 2026
Traders Eye $850 Million ThomasLloyd Deal as Roman DBDR Stock Stays Quiet

New York, May 27, 2026, 13:07 (EDT)

  • DRDB finished most recent trade at $10.52, edging up less than 0.1%. Shares moved between $10.50 and $10.52.
  • The stock is trading just under its stated $10.56 per share redemption value.
  • The ThomasLloyd Climate Solutions deal is still the main driver.

Roman DBDR Acquisition Corp. II stuck close to $10.52 Wednesday, as investors paid more attention to the SPAC’s coming merger with ThomasLloyd Climate Solutions than to its limited activity now. The Nasdaq stock edged up less than 0.1% in a narrow range between $10.50 and $10.52. Volume was about 115,000 shares.

Roman DBDR is sitting just below its $10.56 per-share redemption value from March 31. That redemption value is what a SPAC investor can pull from the trust account instead of staying in after the deal vote.

SPACs often focus on the redemption spread, sometimes more than earnings figures. Roman’s merger filing states that Class A holders can redeem for their pro-rata share of trust money in the ThomasLloyd merger.

Markets saw a mixed session. QQQ eased 0.15%, SPY was flat. Brookfield Renewable Partners added 0.6%, with Clearway Energy up 1.7% as renewables found some buyers. Those aren’t direct comps, but they line up more with the clean-energy pool Roman is eyeing than with traditional sector shells.

Roman and ThomasLloyd said in February that they had agreed to the deal. The pre-transaction value for ThomasLloyd comes in at $850 million. The combined company would be set up as a holding company in England and Wales and is planning to trade on Nasdaq with the ticker TCSG.

The proposed deal is expected to bring in over $240 million in gross proceeds from Roman’s trust and an expected PIPE, before redemptions and deal costs. There isn’t a minimum cash closing condition, which can simplify closing but could mean less cash if investors pull funds.

ThomasLloyd CEO Michael Sieg called energy infrastructure an “economic and national security imperative” in February, citing AI and data centre needs. The group is marketing its platform as a solution for power demand, decarbonisation, and climate-finance. Reuters

Roman is making changes to its team tied to the deal. The company announced May 15 that Hunter Gary joined its board and Al Basseri is now chief technology officer. Basseri said “global power demand is surging” as sustainable energy lines up with tech infrastructure. Business Wire

Roman’s latest quarterly report didn’t offer many surprises. The company posted a net loss of $235,067 for the first quarter and said there was $242.8 million in its trust account as of March 31. Cash on hand outside the trust was just $53,490. Management also flagged “substantial doubt” about the company’s ability to keep operating, saying more support is likely needed. Stock Titan

The trade has risks if there are big redemptions, the registration statement takes longer, shareholder votes don’t pass, or ThomasLloyd misses closing terms in the merger agreement. Roman’s 8-K notes both sides can walk away for certain reasons if the deal isn’t closed by Aug. 31, or by Nov. 16 if the SEC hasn’t signed off on the registration statement.

DRDB is still trading like a deal-arb name, not a growth bet. Shares at $10.52 sit about 0.4% under the stated redemption value. The path higher doesn’t hang on Wednesday’s moves—it comes down to whether ThomasLloyd can clear the proxy process and convince SPAC investors to forgo cash at the vote.

Stock Market Today

  • Rolls-Royce Shares Down 5.9% Over 3 Months: £1,000 Investment Now Worth £941
    May 27, 2026, 1:02 PM EDT. Rolls-Royce (LSE: RR.) shares fell 5.9% in three months, sliding from 1,386p to about 1,248p. A £1,000 investment three months ago would now be worth around £941, reflecting a £59 loss. The decline reflects geopolitical tensions impacting civil aviation, including US-Iran conflicts raising fuel supply concerns. Despite this, Rolls-Royce forecasts revenue growth from £22.7 billion this year to £27.54 billion by 2028, aided by business diversification beyond civil aviation. The stock trades at a moderate 18 P/E (price-to-earnings ratio), suggesting less valuation stretch compared to many growth stocks. Alternatives like AstraZeneca, valued at a 41.8% discount via discounted cash flow models but facing patent risks, and British American Tobacco also merit investor attention for growth and income potential.